(Q46105113)

English

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

scientific article published on May 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413 (English)

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

phase III clinical trial

0 references

Adaptive radiation therapy

0 references

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

author name string

Radiation Therapy Oncology Group 9413

14

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

M. Roach

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

M. DeSilvio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

C. Lawton

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

V. Uhl

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

M. Machtay

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

M. J. Seider

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

M. Rotman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

C. Jones

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

S. O. Asbell

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

R. K. Valicenti

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

S. Han

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

C. R. Thomas

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

W. S. Shipley

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743142

1 January 2024

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

15 May 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743142

1 January 2024

full work available at URL

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.05.004

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

21

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

1904-1911

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

Radical prostatectomy or radiotherapy in carcinoma of prostate. The dilemma continues.

4

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

5

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

7

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

8

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate cancer trials

9

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06

10

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer.

11

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Lack of prostate cancer radiosensitization by androgen deprivation

13

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

14

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

15

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

16

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

The role of the urethrogram during simulation for localized prostate cancer

17

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Nonparametric Estimation from Incomplete Observations

18

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

21

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Practical application of biochemical failure definitions: what to do and when to do it

23

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Considerations for monitoring and evaluating treatment effects in clinical trials.

24

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Designs for group sequential tests.

25

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study.

26

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer

27

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

28

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

29

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients

30

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

31

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy

33

1 reference

10.1200/JCO.2003.05.004

https://api.crossref.org/works/10.1200/JCO.2003.05.004

1 January 2024

Identifiers

10.1200/JCO.2003.05.004

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/12743142

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46105113&oldid=2184242733"